Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06852573 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 28, 2025 (before its estimated February 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an open, single-arm, phase I clinical study of ZM001 in patients with refractory systemic lupus erythematosus
Trial Details
NCT Number NCT06852573
Lead Sponsor Beijing Immunochina Medical Science & Technology Co., Ltd.
Collaborators: Peking Union Medical College Hospital
Conditions Systemic Lupus Erythematosus
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov